In 2025, ongoing trials are evaluating whether MEK inhibition can delay or prevent malignant transformation, or serve as a neoadjuvant strategy to shrink MPNST prior to surgery (Gross et al., 2024)
Compounded products are not FDA-approved or evaluated by the FDA for safety, quality, and efficacy
Work through it in order before concluding the peptide isn't working
Liraglutide vs Semaglutide: Whats Actually Different Beyond the Name Which One Is Better for Fat Loss, Side Effects, and Long-Term Success
In October 2025, the Welsh government confirmed plans to develop a new clinical pathway to treat obesity as a chronic, recurring condition and support equitable access to weight-loss drugs and wrap-around care, including in appropriate primary care and community settings 42